Menstrual Cycle Cycle Biomarkers

Ovulation, a sign of health

Vigil P, Lyon C, Flores B, Rioseco H, Serrano F

Published November 2017 The Linacre Quarterly, 84(4), 343-355
DOI 10.1080/00243639.2017.1394053 PMID 29255329 PMC PMC5730019

RRM Academy Synopsis

Regular ovulation is a sign of health, a review argues

A 2017 narrative review argues that regular ovulation is a sign of a woman's overall health. The authors trace the ovarian continuum from fetal life to menopause. They say cervical mucus and body temperature help women spot ovulation.

Key Findings

  • The authors state that women begin their reproductive years with approximately five hundred thousand follicles, and only around five hundred are released in ovulation.
  • Cycles of normal length can still be anovulatory, the authors write, so regular ovulation is the sign that indicates good health.
  • The authors describe apps built on the rhythm method as inaccurate, and apps based on cervical mucus charting and basal body temperature as more accurate.
  • The review names hypothalamic, pituitary, thyroid, adrenal, ovarian and metabolic disorders as common hormonal causes of ovulatory dysfunction.
  • The authors define a normal ovulatory cycle as 24 to 36 days long, with a luteal phase of 11 to 17 days.

Interpretation

This narrative review traces the ovarian continuum across a woman's life, from fetal life to menopause. The authors argue that regular ovulation, more than cycle length, is the real sign of hormonal health. They link that pattern to the hypothalamus, pituitary, thyroid, adrenal glands, ovaries and metabolism. They point to cervical mucus and basal body temperature as the signs that let women and clinicians track it. The findings support larger studies on biomarker-based ovulation tracking in routine care.

RRM Context

Restorative reproductive medicine treats an irregular ovulation pattern as a clue to find an underlying cause. This review lays out that reasoning across a woman's life. Cervical mucus charting methods, such as the Billings Ovulation Method, track the signs it describes.

Abstract

The concept of the ovarian continuum can be understood as a process that occurs during a woman's lifetime and begins during intrauterine life with fertilization. Women start their reproductive years with approximately five hundred thousand follicles containing oocytes, of which only around five hundred will be released during ovulation. Ovulation has been recognized as an event linked with reproduction; however, recent evidence supports the role of ovulation as a sign of health. The use of biomarkers that help women recognize ovulation enables them to identify their health status. This knowledge helps medical healthcare providers in the prevention, diagnosis, and treatment of different pathologies related with endocrine disorders, gynecological abnormalities, autoimmune, genetic, and neoplastic diseases, as well as pregnancy-related issues. The knowledge of the ovarian continuum and the use of biomarkers to recognize ovulation should be considered a powerful tool for women and medical professionals.

Summary

The ovarian continuum is a process that occurs during a woman's lifetime. It begins during intrauterine life with fertilization and ends with menopause. This process can be greatly affected by different conditions such as changes in hormonal levels and illnesses. Therefore, understanding and promoting the knowledge and use of biomarkers of ovulation in women is a key aspect to consider when evaluating their health status. The knowledge and education about the ovarian continuum should be taken into account as a powerful tool for women and medical professionals.

Topics

By this author

Related research

Menstrual Cycle › Cycle Biomarkers › Hormonal Markers · Longevity and Reproductive Aging › Lifespan Health › Cycle as a Lifespan Health Marker · Reproductive Endocrinology › Ovulation Physiology › Ovarian Reserve
Pilar Vigil, Carolina Lyon, Betsi Flores, Hernán Rioseco, Felipe Serrano
P Vigil, C Lyon, B Flores, H Rioseco, F Serrano
PMID 29255329 29255329 DOI 10.1080/00243639.2017.1394053 10.1080/00243639.2017.1394053 Vigil et al. 2017, Vigil 2017